Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience.
OBJECTIVE
To prospectively determine if pulsed arterial spin-labeling perfusion magnetic resonance (MR) imaging depicts regional cerebral hypoperfusion in subjects with Alzheimer disease (AD) and mild cognitive impairment (MCI), compared with perfusion in cognitively normal (CN) subjects, that is consistent with results of fluorodeoxyglucose (FDG) positron emission tomography (PET) and hexamethylpropyleneamine oxime (HMPAO) single photon emission computed tomography (SPECT) studies of similar populations.


METHODS
Institutional review board approval and informed consent were obtained. Twenty subjects with AD (13 men, seven women; mean age, 72.9 years), 18 with MCI (nine men, nine women; mean age, 73.3 years), and 23 CN subjects (10 men, 13 women; mean age, 72.9 years) underwent arterial spin-labeling and volumetric T1-weighted structural MR imaging. Perfusion images were coregistered to structural images, corrected for partial volume effects (PVEs) with information from the structural image to determine tissue content of perfusion voxels, and normalized to a study-specific template. Analyses of perfusion differences between groups, with and without corrections for PVEs, were performed on a voxel-by-voxel basis with a one-tailed fixed-effects analysis of covariance model adjusted for age. In addition, tests were performed with and without accounting for global perfusion.


RESULTS
The AD group showed significant regional hypoperfusion, compared with the CN group, in the right inferior parietal cortex extending into the bilateral posterior cingulate gyri (P <.001), bilateral superior and middle frontal gyri (P <.001), and left inferior parietal lobe (P=.007). When PVEs from underlying cortical gray matter atrophy were accounted for, the AD group still showed hypoperfusion in the right inferior parietal lobe extending into the bilateral posterior cingulate gyri (P <.001) and left (P=.003) and right (P=.012) middle frontal gyri. With a more liberal voxel-level threshold of P <.01, the MCI group showed significant regional hypoperfusion relative to the CN group in the inferior right parietal lobe (P=.046), similar to the region of greatest significance in the AD group.


CONCLUSIONS
Arterial spin-labeling MR imaging showed regional hypoperfusion with AD, in brain regions similar to those seen in FDG PET and HMPAO SPECT studies of similar populations; this hypoperfusion persists after accounting for underlying cortical gray matter atrophy.
Johnson
Nathan A
NA
MR Research Unit, VA Medical Center, 4150 Clement St 114M San Francisco, CA 94107, USA.
Jahng
Geon-Ho
GH
Weiner
Michael W
MW
Miller
Bruce L
BL
Chui
Helena C
HC
Jagust
William J
WJ
Gorno-Tempini
Maria L
ML
Schuff
Norbert
N
D000368:Aged; D000544:Alzheimer Disease / Q000000981:diagnostic imaging / Q000503:physiopathology*; D000704:Analysis of Variance; D001921:Brain / Q000098:blood supply*; D002560:Cerebrovascular Circulation / Q000502:physiology; D003072:Cognition Disorders / Q000000981:diagnostic imaging / Q000503:physiopathology*; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D049268:Positron-Emission Tomography; D011446:Prospective Studies; D019275:Radiopharmaceuticals; D013113:Spin Labels; D019690:Technetium Tc 99m Exametazime; D015899:Tomography, Emission-Computed, Single-Photon
D019275:Radiopharmaceuticals; D013113:Spin Labels; D019690:Technetium Tc 99m Exametazime
Neurol Clin. 2000 Nov;18(4):885-902
11072266
J Nucl Med. 2000 Jul;41(7):1155-62
10914904
Hum Brain Mapp. 2000 Nov;11(3):223-32
11098800
Neuroreport. 2001 Mar 26;12(4):851-5
11277595
Neurology. 2001 Jun 12;56(11):1545-51
11402113
J Neurol Neurosurg Psychiatry. 2001 Sep;71(3):315-21
11511703
Neuroimage. 2001 Jul;14(1 Pt 1):21-36
11525331
J Nucl Med. 2002 Mar;43(3):304-11
11884488
Acta Neurol Scand. 2002 Apr;105(4):261-9
11939938
Brain. 2002 Aug;125(Pt 8):1772-81
12135968
Eur J Nucl Med Mol Imaging. 2002 Nov;29(11):1502-5
12397471
Magn Reson Med. 2003 Feb;49(2):307-14
12541251
Radiology. 2003 Feb;226(2):315-36
12563122
Acta Neurol Scand Suppl. 2003;179:52-76
12603252
Eur Neurol. 2003;49(3):142-5
12646756
Neurology. 2003 Apr 22;60(8):1374-7
12707450
Neuroimage. 2003 Jul;19(3):1137-44
12880839
Arch Neurol. 2003 Aug;60(8):1066-72
12925361
Brain. 2003 Sep;126(Pt 9):1955-67
12821520
Alzheimer Dis Assoc Disord. 2003 Jul-Sep;17 Suppl 4:S105-13
14512816
J Psychiatr Res. 1975 Nov;12(3):189-98
1202204
J Gerontol. 1982 May;37(3):323-9
7069156
J Am Geriatr Soc. 1985 Jan;33(1):2-3
3965552
J Comput Assist Tomogr. 1990 Jul-Aug;14(4):561-70
2370355
J Cereb Blood Flow Metab. 1992 Jul;12(4):571-83
1618936
Neurology. 1993 Nov;43(11):2412-4
8232972
Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):33-7
8278387
JAMA. 1995 Mar 22-29;273(12):942-7
7884953
Neurosci Lett. 1995 Feb 15;186(1):17-20
7783942
N Engl J Med. 1996 Mar 21;334(12):752-8
8592548
Neurology. 1996 Aug;47(2):454-61
8757020
Neurobiol Aging. 1997 Jul-Aug;18(4):351-7
9330961
Neuroimage. 1995 Jun;2(2):148-56
9343597
Neurology. 1998 Jun;50(6):1563-71
9633695
Neurology. 1998 Jun;50(6):1585-93
9633698
J Neural Transm Suppl. 1998;53:127-40
9700651
J Neural Transm (Vienna). 1998;105(8-9):821-37
9869321
Arch Neurol. 1999 Mar;56(3):303-8
10190820
Magn Reson Med. 1999 Jun;41(6):1246-54
10371458
Eur J Radiol. 1999 May;30(2):115-24
10401592
Ann Neurol. 2000 Jan;47(1):93-100
10632106
Neurobiol Aging. 2000 Mar-Apr;21(2):289-92
10867213
J Nucl Med. 2000 Nov;41(11):1842-8
11079492